118 related articles for article (PubMed ID: 3079086)
1. Histologic response to OKT3 therapy for hepatic allograft rejection.
Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
[No Abstract] [Full Text] [Related]
2. Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
Rohrer RJ; Jenkins RL; Khettry U; Pinson CW; Gallik-Karlson C; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):2249-50. PubMed ID: 2652729
[No Abstract] [Full Text] [Related]
3. Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
McDiarmid SV; Millis M; Terashita G; Ament ME; Busuttil R; Terasaki P
Transplant Proc; 1990 Aug; 22(4):1774-6. PubMed ID: 2117806
[No Abstract] [Full Text] [Related]
4. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083
[No Abstract] [Full Text] [Related]
5. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Hricik DE; Zarconi J; Schulak JA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
[No Abstract] [Full Text] [Related]
6. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
7. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.
Krom RA; Wiesner RH; Haagsma EB; Ludwig J; Gips CH; Grond AJ; Houthoff HJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085
[No Abstract] [Full Text] [Related]
8. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F
Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
[No Abstract] [Full Text] [Related]
9. OKT3 immunoprophylaxis in human liver transplantation.
Mühlbacher F; Steininger R; Längle F; Sautner T; Gnant M; Götzinger P; Piza F; Popow T
Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
[No Abstract] [Full Text] [Related]
10. Preservation of renal function using OKT3 in liver transplant patients.
Millis JM; Baquerizo A; Saleh S; Danovitch GM; Busuttil RW
Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
[No Abstract] [Full Text] [Related]
11. Results and problems in pediatric liver transplantation in the Cambridge/Kings College Hospital series: 1968 to July 1986.
Jamieson NV; Calne RY; Rolles K; Barnes ND; Mowat AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2447-8. PubMed ID: 3274534
[No Abstract] [Full Text] [Related]
12. OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.
Woodle ES; Thistlethwaite JR; Emond JC; Whitington PF; Black DD; Aran PP; Baker AL; Stuart FP; Broelsch CE
Transplant Proc; 1990 Aug; 22(4):1765-6. PubMed ID: 2117803
[No Abstract] [Full Text] [Related]
13. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
14. Plasma levels of leukotriene B4 during hepatic allograft rejection.
González J; Pardo F; Cienfuegos JA; Hernández JL; de Villa V; Torramadé J; Diaz MC; Pardo FJ; Ortigosa CR
Transplant Proc; 1992 Feb; 24(1):143-4. PubMed ID: 1311470
[No Abstract] [Full Text] [Related]
15. Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation.
Steininger R; Mühlbacher F; Hamilton G; Längle F; Gnant M; Popow T; Sautner T; Götzinger P; Wamser P; Stockenhuber F
Transplant Proc; 1991 Aug; 23(4):2269-71. PubMed ID: 1908154
[No Abstract] [Full Text] [Related]
16. Liver allograft rejection: analysis of OKT3 rescue therapy.
McCaughan GW; Strasser S; Dolan P; Sheil AG
Transplant Proc; 1992 Oct; 24(5):2250-1. PubMed ID: 1413044
[No Abstract] [Full Text] [Related]
17. Rescue of severe steroid-resistant rejection with OKT3.PAN.
Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
[No Abstract] [Full Text] [Related]
18. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
[No Abstract] [Full Text] [Related]
19. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
[No Abstract] [Full Text] [Related]
20. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
